menu search

Merck's covid pill could be riskier than investors think

Merckā€˜s announcement that its antiviral molnupiravir had halved hospitalizations in a trial of high-risk Covid-19 patients was met with enthusiasm o...

October 5, 2021, 4:30 am


Search within

Pages Search Results: